CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Quest Diagnostics - DGX CFD

    125.78
    0.9%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    Trading сonditions
    Spread 0.28
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026179 %
    Charges from full value of position ($-4.97)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026179%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003957 %
    Charges from full value of position ($0.75)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003957%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Quest Diagnostics Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 126.86
    Open* 126.33
    1-Year Change* -11.76%
    Day's Range* 125.37 - 126.93
    52 wk Range 119.59-150.57
    Average Volume (10 days) 1.00M
    Average Volume (3 months) 19.94M
    Market Cap 15.09B
    P/E Ratio 20.14
    Shares Outstanding 112.44M
    Revenue 9.30B
    EPS 6.67
    Dividend (Yield %) 2.11577
    Beta 0.91
    Next Earnings Date Feb 1, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Apr 18, 2024 125.72 -0.30 -0.24% 126.02 127.16 125.23
    Apr 17, 2024 126.86 0.20 0.16% 126.66 127.60 126.55
    Apr 16, 2024 127.31 -1.09 -0.85% 128.40 129.26 127.31
    Apr 15, 2024 128.56 -0.44 -0.34% 129.00 129.59 127.97
    Apr 12, 2024 128.45 0.50 0.39% 127.95 130.02 127.95
    Apr 11, 2024 129.88 -1.70 -1.29% 131.58 131.70 129.00
    Apr 10, 2024 131.53 -0.01 -0.01% 131.54 132.64 130.86
    Apr 9, 2024 132.66 2.66 2.05% 130.00 132.72 129.73
    Apr 8, 2024 129.96 0.42 0.32% 129.54 131.59 129.35
    Apr 5, 2024 130.54 1.08 0.83% 129.46 131.04 128.94
    Apr 4, 2024 131.44 -0.71 -0.54% 132.15 133.96 131.33
    Apr 3, 2024 132.33 0.43 0.33% 131.90 133.37 130.85
    Apr 2, 2024 132.19 -1.78 -1.33% 133.97 134.30 131.21
    Apr 1, 2024 134.61 1.93 1.45% 132.68 135.36 130.20
    Mar 28, 2024 133.07 2.18 1.67% 130.89 133.33 129.59
    Mar 27, 2024 130.97 2.61 2.03% 128.36 131.03 127.87
    Mar 26, 2024 128.73 0.56 0.44% 128.17 129.67 127.82
    Mar 25, 2024 129.21 -0.13 -0.10% 129.34 129.48 128.26
    Mar 22, 2024 129.23 0.71 0.55% 128.52 129.31 127.78
    Mar 21, 2024 128.69 1.66 1.31% 127.03 128.89 126.68

    Quest Diagnostics Events

    Time (UTC) Country Event
    Tuesday, April 23, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q1 2024 Quest Diagnostics Inc Earnings Call
    Q1 2024 Quest Diagnostics Inc Earnings Call

    Forecast

    -

    Previous

    -

    Time (UTC)

    12:30

    Country

    US

    Event

    Q1 2024 Quest Diagnostics Inc Earnings Release
    Q1 2024 Quest Diagnostics Inc Earnings Release

    Forecast

    -

    Previous

    -
    Thursday, May 16, 2024

    Time (UTC)

    14:30

    Country

    US

    Event

    Quest Diagnostics Inc Annual Shareholders Meeting
    Quest Diagnostics Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -

    Time (UTC)

    14:30

    Country

    US

    Event

    Quest Diagnostics Inc Annual Shareholders Meeting
    Quest Diagnostics Inc Annual Shareholders Meeting

    Forecast

    -

    Previous

    -
    Wednesday, July 24, 2024

    Time (UTC)

    12:30

    Country

    US

    Event

    Q2 2024 Quest Diagnostics Inc Earnings Release
    Q2 2024 Quest Diagnostics Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 9883 10788 9437 7726 7531
    Revenue 9883 10788 9437 7726 7531
    Cost of Revenue, Total 6418 6510 5720 5002 4870
    Gross Profit 3465 4278 3717 2724 2661
    Total Operating Expense 8455 8407 7466 6495 6430
    Selling/General/Admin. Expenses, Total 1818 1680 1509 1403 1359
    Depreciation / Amortization 120 103 103 96 90
    Unusual Expense (Income) 92 116 134 90 126
    Other Operating Expenses, Total 7 -2 -96 -15
    Operating Income 1428 2381 1971 1231 1101
    Interest Income (Expense), Net Non-Operating -193 -151 -163 -175 -167
    Other, Net 369 76 20 -8
    Net Income Before Taxes 1235 2599 1884 1076 926
    Net Income After Taxes 971 2002 1424 829 730
    Minority Interest -69 -85 -68 -48 -52
    Equity In Affiliates 44 78 75 57 44
    Net Income Before Extra. Items 946 1995 1431 838 722
    Total Extraordinary Items 0 20 14
    Net Income 946 1995 1431 858 736
    Total Adjustments to Net Income -4 -7 -6 -3 -3
    Income Available to Common Excl. Extra. Items 942 1988 1425 835 719
    Income Available to Common Incl. Extra. Items 942 1988 1425 855 733
    Diluted Net Income 942 1988 1425 855 733
    Diluted Weighted Average Shares 118 128 136 136 139
    Diluted EPS Excluding Extraordinary Items 7.98305 15.5312 10.4779 6.13971 5.17266
    Dividends per Share - Common Stock Primary Issue 2.6 2.42 2.21 2.12 1.95
    Diluted Normalized EPS 8.59605 16.2293 11.2227 6.64956 5.88727
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total revenue 2295 2338 2331 2333 2486
    Revenue 2295 2338 2331 2333 2486
    Cost of Revenue, Total 1539 1546 1550 1556 1612
    Gross Profit 756 792 781 777 874
    Total Operating Expense 1953 1990 2026 2198 2094
    Selling/General/Admin. Expenses, Total 376 409 430 531 457
    Depreciation / Amortization 27 28 26 39 27
    Unusual Expense (Income) 6 7 19 51 13
    Operating Income 342 348 305 135 392
    Interest Income (Expense), Net Non-Operating -40 -37 -35 -32 -33
    Other, Net -3 6 7 6 -8
    Net Income Before Taxes 299 317 277 109 351
    Net Income After Taxes 231 242 212 113 270
    Minority Interest -12 -14 -15 -15 -20
    Equity In Affiliates 6 7 5 3 6
    Net Income Before Extra. Items 225 235 202 101 256
    Net Income 225 235 202 101 256
    Total Adjustments to Net Income -2 -1 -1 0 -2
    Income Available to Common Excl. Extra. Items 223 234 201 101 254
    Income Available to Common Incl. Extra. Items 223 234 201 101 254
    Diluted Net Income 223 234 201 101 254
    Diluted Weighted Average Shares 114 114 113 115 118
    Diluted EPS Excluding Extraordinary Items 1.95614 2.05263 1.77876 0.87826 2.15254
    Dividends per Share - Common Stock Primary Issue 0.71 0.71 0.66 0.66 0.66
    Diluted Normalized EPS 1.9968 2.09951 1.90745 1.16652 2.23729
    Other Operating Expenses, Total 5 0 1 21 -15
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1898 2741 3058 2490 1390
    Cash and Short Term Investments 315 872 1158 1192 135
    Cash & Equivalents 315 872 1158 1192 135
    Total Receivables, Net 1195 1438 1523 1063 1012
    Accounts Receivable - Trade, Net 1195 1438 1520 1063 1012
    Total Inventory 192 208 223 123 99
    Prepaid Expenses 196 223 154 112 144
    Other Current Assets, Total
    Total Assets 12837 13611 14026 12843 11003
    Property/Plant/Equipment, Total - Net 2351 2304 2231 1971 1288
    Property/Plant/Equipment, Total - Gross 5688 5392 5223 4747 3970
    Accumulated Depreciation, Total -3337 -3088 -2992 -2776 -2682
    Goodwill, Net 7220 7095 6873 6619 6563
    Intangibles, Net 1092 1167 1167 1121 1207
    Long Term Investments 132 141 521 482 436
    Other Long Term Assets, Total 144 163 176 160 119
    Total Current Liabilities 1551 1753 1776 1990 1485
    Accounts Payable 324 357 446 263 222
    Accrued Expenses 1034 1189 1056 730 599
    Notes Payable/Short Term Debt 92 116 153 88 98
    Current Port. of LT Debt/Capital Leases 2 2 2 804 464
    Other Current Liabilities, Total 99 89 119 105 102
    Total Liabilities 6944 7167 7267 7202 5787
    Total Long Term Debt 3978 4010 4013 3966 3429
    Long Term Debt 3971 3985 3988 3936 3429
    Minority Interest 114 118 132 122 128
    Other Liabilities, Total 1006 1286 1346 1124 745
    Total Equity 5893 6444 6759 5641 5216
    Common Stock 2 2 2 2 2
    Additional Paid-In Capital 2295 2260 2841 2722 2667
    Retained Earnings (Accumulated Deficit) 8290 7649 9303 8174 7602
    Treasury Stock - Common -4673 -3453 -5366 -5218 -4996
    Other Equity, Total -22 -15 -29 -47 -59
    Total Liabilities & Shareholders’ Equity 12837 13611 14026 12843 11003
    Total Common Shares Outstanding 111 119 133 133 135
    Unrealized Gain (Loss) 1 1 8 8 0
    Capital Lease Obligations 7 25 25 30
    Deferred Income Tax 295
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 1815 1733 1814 1898 2334
    Cash and Short Term Investments 143 126 175 315 700
    Cash & Equivalents 143 126 175 315 700
    Total Receivables, Net 1281 1235 1254 1195 1280
    Accounts Receivable - Trade, Net 1281 1235 1254 1195 1280
    Total Inventory 184 184 190 192 183
    Prepaid Expenses 207 188 195 196 171
    Total Assets 13482 13425 12794 12837 13223
    Property/Plant/Equipment, Total - Net 2437 2425 2384 2351 2314
    Goodwill, Net 7732 7733 7241 7220 7190
    Intangibles, Net 1219 1247 1077 1092 1115
    Long Term Investments 130 135 128 132 138
    Other Long Term Assets, Total 149 152 150 144 132
    Total Current Liabilities 1618 1875 1355 1551 1602
    Payable/Accrued 1157 1201 1198 1396 1447
    Accrued Expenses 157 156 155 153 153
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 304 518 2 2 2
    Total Liabilities 7057 7176 6744 6944 6988
    Total Long Term Debt 3946 3777 3975 3978 3980
    Long Term Debt 3946 3777 3975 3978 3980
    Minority Interest 114 115 115 114 114
    Other Liabilities, Total 1379 1409 1299 1301 1292
    Total Equity 6425 6249 6050 5893 6235
    Common Stock 2 2 2 2 2
    Additional Paid-In Capital 2302 2284 2266 2295 2272
    Retained Earnings (Accumulated Deficit) 8711 8566 8412 8290 8263
    Treasury Stock - Common -4570 -4587 -4612 -4673 -4271
    Other Equity, Total -20 -16 -18 -21 -31
    Total Liabilities & Shareholders’ Equity 13482 13425 12794 12837 13223
    Total Common Shares Outstanding 112 112 112 111 114
    Capital Lease Obligations
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 1015 2080 1499 906 788
    Cash From Operating Activities 1718 2233 2005 1243 1200
    Cash From Operating Activities 437 408 361 329 309
    Deferred Taxes 1 -57 85 15 73
    Non-Cash Items 146 -285 38 -42 79
    Cash Taxes Paid 283 709 360 202 84
    Cash Interest Paid 156 159 201 192 174
    Changes in Working Capital 119 87 22 35 -49
    Cash From Investing Activities -543 21 -772 -411 -801
    Capital Expenditures -404 -403 -418 -400 -383
    Other Investing Cash Flow Items, Total -139 424 -354 -11 -418
    Cash From Financing Activities -1732 -2540 -1267 225 -401
    Financing Cash Flow Items -140 -159 -29 -87 -36
    Total Cash Dividends Paid -305 -309 -297 -286 -266
    Issuance (Retirement) of Stock, Net -1285 -2070 -136 -234 -223
    Issuance (Retirement) of Debt, Net -2 -2 -805 832 124
    Net Change in Cash -557 -286 -34 1057 -2
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 217 1015 899 623 373
    Cash From Operating Activities 94 1718 1384 882 480
    Cash From Operating Activities 107 437 321 213 106
    Deferred Taxes -4 1 45 -20 -43
    Non-Cash Items 26 146 93 71 22
    Cash Taxes Paid 33 283 187 182 23
    Cash Interest Paid 32 156 110 78 32
    Changes in Working Capital -252 119 26 -5 22
    Cash From Investing Activities -158 -543 -369 -251 -169
    Capital Expenditures -127 -404 -257 -139 -63
    Other Investing Cash Flow Items, Total -31 -139 -112 -112 -106
    Cash From Financing Activities -76 -1732 -1187 -713 -471
    Financing Cash Flow Items -27 -140 -105 -55 -33
    Total Cash Dividends Paid -74 -305 -230 -152 -74
    Issuance (Retirement) of Stock, Net 25 -1285 -851 -505 -363
    Issuance (Retirement) of Debt, Net 0 -2 -1 -1 -1
    Net Change in Cash -140 -557 -172 -82 -160

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Quest Diagnostics Company profile

    Founded in 1967, Quest Diagnostics (DGX) is the leading global provider of diagnostic information services. Headquartered in Madison, New Jersey, the company has a team of 43,000 employees that operate 2,200 patient service centres across the country. Annually, Quest serves one in three adult Americans and half the hospitals and physicians in the USA. Quest Diagnostics delivers diagnostic testing services for neurological disorders, cardiovascular disease, infectious diseases and cancer. With an annual revenue of $7.5 billion the company is included to the S&P 500 index. The Quest Diagnostics share price (DGX) is set and traded on the New York Stock Exchange (NYSE).
    Industry: Healthcare Facilities & Services (NEC)

    500 Plaza Drive
    SECAUCUS
    NEW JERSEY 07094
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

    Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

    07:56, 17 April 2024

    US Earnings Season : JP Morgan, Citigroup, Wells Fargo

    The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

    16:03, 11 April 2024

    Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

    The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

    09:22, 11 April 2024

    US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

    US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

    15:11, 9 April 2024

    How escalating geopolitical tensions are impacting oil markets

    The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

    13:34, 4 April 2024

    A way forward: a roundup of recent central bank decisions

    Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

    12:47, 22 March 2024

    Bank of Japan Preview: will the BOJ end negative interest rates?

    The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

    08:44, 18 March 2024

    People also watch

    XRP/USD

    0.51 Price
    -0.530% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01168

    BTC/USD

    64,817.50 Price
    +1.930% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 106.00

    ETH/USD

    3,106.58 Price
    +1.080% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 6.00

    Gold

    2,381.56 Price
    +0.110% 1D Chg, %
    Long position overnight fee -0.0190%
    Short position overnight fee 0.0108%
    Overnight fee time 21:00 (UTC)
    Spread 0.30

    Still looking for a broker you can trust?

    Join the 610,000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading